Live Breaking News & Updates on Kunzmannk Patisiran

Stay updated with breaking news from Kunzmannk patisiran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Issues CRL for Patisiran in Treatment of ATTR Cardiomyopathy

Announced on October 9, the decision to issue a CRL is based on the FDA's belief the clinical meaningfulness of patisiran’s treatment effects for the cardiomyopathy of ATTR amyloidosis had not been established. ....

United States , Kunzmannk Patisiran , Campbellp Patisiran , Ahmad Masri , Christopher Oconnor , Yvonne Greenstreet , Alnylam Pharmaceuticals , Investor Relations Alnylam Pharmaceuticals Inc , Oregon Health , Renal Drugs Advisory Committee , Vascular Institute , Hypertrophic Cardiomyopathy Center , Drug Administration , Sciences University , Complete Response Letter , Chief Executive Officer , Annual Congress , Heart Failure Association , European Society , New Drug Application , Christophero Connor , Inova Heart , Supplemental New Drug Application , Patisiran Onpattro , Attr Cm , Patisiran In Cardiomyopathy ,